Defective Olfactomedin-2 connects adipocyte dysfunction to obesity.

Area of Science:

• Biochemistry
• Cell Biology
• Metabolic Research

Background:

• Olfactomedin-2 (OLFM2) is a glycoprotein involved in energy homeostasis.
• Its role in adipocyte biology and obesity is not fully understood.

Purpose of the Study:

• To investigate the function of OLFM2 in adipocytes.
• To determine the association between OLFM2 expression and obesity.

Main Methods:

• Studied OLFM2 expression in adipocytes during differentiation and inflammation.
• Performed loss- and gain-of-function experiments in cell lines and primary human adipocytes.
• Utilized whole-body and adipose-specific Olfm2 knockout mouse models.

Main Results:

• OLFM2 expression is specific to adipocytes and inversely correlated with obesity.
• OLFM2 levels increase during adipogenesis and decrease in inflamed adipocytes.
• OLFM2 deficiency impairs adipocyte differentiation and enhances it upon overproduction.
• In vivo studies showed impaired adipose cell cycle gene expression, fat mass accretion, and metabolic dysfunction in Olfm2-depleted mice.

Conclusions:

• OLFM2 plays a critical role in adipocyte biology.
• Reduced adipose OLFM2 is causally linked to obesity pathophysiology.